| Not Yet Recruiting | Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma Aft NCT07076498 | M.D. Anderson Cancer Center | Phase 1 |
| Not Yet Recruiting | A Study for Cerebral Open Flow Microperfusion NCT07089758 | Mayo Clinic | N/A |
| Not Yet Recruiting | Monitoring of Neurological Symptoms, Treatment Tolerance, and Quality of Life Using the Resilience PRO Electro NCT07439302 | Assistance Publique - Hôpitaux de Paris | N/A |
| Not Yet Recruiting | A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade Gliomas NCT04745156 | Medical College of Wisconsin | N/A |
| Not Yet Recruiting | Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma NCT07416188 | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 1 / Phase 2 |
| Recruiting | Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EG NCT07326566 | Black Diamond Therapeutics, Inc. | Phase 2 |
| Not Yet Recruiting | Neuromodulation-Induced Cortical Prehabilitation in High Grade Glioma Near the Motor Pathway: Cortical Plastic NCT07471100 | Azienda Sanitaria dell'Alto Adige | N/A |
| Not Yet Recruiting | Language Network Prehab Via fMRI Neurofeedback NCT07488780 | Yale University | N/A |
| Not Yet Recruiting | Vorasidenib Guided by AGX PET in Recurrent/Low-grade Glioma NCT07469735 | Huashan Hospital | N/A |
| Not Yet Recruiting | Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG) NCT07210632 | Eben Rosenthal | EARLY_Phase 1 |
| Not Yet Recruiting | Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICG NCT07438860 | Tiffany Hodges | Phase 1 |
| Not Yet Recruiting | A First-in-Human Study of the CIPHER System During Brain Surgery for Newly Diagnosed Glioma NCT07465796 | Coherence Neuro Australia Pty Limited | N/A |
| Not Yet Recruiting | Using the Epitranscriptome to Diagnose and Treat Gliomas NCT06575452 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Not Yet Recruiting | A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma NCT07464925 | Tetragon Biosciences Ltd | Phase 1 |
| Recruiting | Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies NCT07486713 | Rigel Pharmaceuticals | Phase 4 |
| Recruiting | Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors NCT07236840 | Tata Memorial Centre | — |
| Not Yet Recruiting | Pharmacoscopy for Patients With Refractory Primary Brain Tumors NCT06804655 | University of Zurich | Phase 2 |
| Recruiting | Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors NCT07411690 | Medical University of Warsaw | — |
| Not Yet Recruiting | DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Y NCT07440290 | Cancer Research UK | Phase 2 / Phase 3 |
| Recruiting | Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Vers NCT07413796 | Medical University of Warsaw | N/A |
| Not Yet Recruiting | Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 NCT07366892 | Leica Microsystems (Schweiz) AG | — |
| Not Yet Recruiting | A Study to Evaluate the Safety and Efficacy of L19TNF With Alkylating Chemotherapy for Patients With Recurrent NCT07120984 | Philogen S.p.A. | Phase 2 |
| Recruiting | Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors NCT07450872 | The Children's Hospital of Zhejiang University School of Medicine | — |
| Recruiting | Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG NCT05555550 | Children's Hospital of Philadelphia | EARLY_Phase 1 |
| Recruiting | Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma NCT07240662 | iOMEDICO AG | — |
| Recruiting | Contrast Enhanced Ultrasound in Neurosurgery to Improve Glioma Visualization and Border Demarcation NCT07050836 | University of Colorado, Denver | EARLY_Phase 1 |
| Not Yet Recruiting | Residual IDH1-Mutant Tumor Cell Quantification Study NCT07219199 | NYU Langone Health | N/A |
| Recruiting | Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of NCT07405372 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | — |
| Not Yet Recruiting | Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery NCT06617208 | Erasmus Medical Center | N/A |
| Recruiting | DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 NCT05770544 | Cancer Research UK | Phase 2 / Phase 3 |
| Recruiting | BIO-SHORT: Biologically Guided Short-Course Hypofractionated RT for Poor-Prognosis GBM NCT07338539 | Tata Memorial Centre | Phase 2 |
| Recruiting | Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors NCT07243470 | Centre Leon Berard | Phase 1 / Phase 2 |
| Recruiting | A Study of 177Lu-PSMA-617 in People With Gliomas NCT07223034 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Not Yet Recruiting | Protoporphyrin Imaging in Multispectral Evaluation of Resections NCT07021573 | Medical University Innsbruck | N/A |
| Active Not Recruiting | [18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes NCT07238322 | Telix Pharmaceuticals (Innovations) Pty Limited | — |
| Recruiting | A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma NCT07074756 | Mayo Clinic | N/A |
| Recruiting | Prospective Real-World Study of Pathology AI for Glioma Molecular Prediction NCT07263711 | Nanfang Hospital, Southern Medical University | — |
| Not Yet Recruiting | Glioma Intraoperative MicroElectroCorticoGraphy NCT06408428 | Institut National de la Santé Et de la Recherche Médicale, France | N/A |
| Not Yet Recruiting | Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients NCT06750458 | Tanta University | Phase 3 |
| Recruiting | Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Trea NCT07025226 | Mayo Clinic | EARLY_Phase 1 |
| Recruiting | Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine NCT07077616 | Biogenea Pharmaceuticals Ltd. | EARLY_Phase 1 |
| Not Yet Recruiting | Amino Acid PET to Assess the Efficacy of IDH Inhibitor Treatments for IDH Mutated Gliomas NCT07017790 | Central Hospital, Nancy, France | — |
| Recruiting | Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoin NCT07179328 | Sunnybrook Health Sciences Centre | Phase 1 |
| Recruiting | ASCENT Intervention for Brain Tumor Patients NCT06099743 | Massachusetts General Hospital | N/A |
| Recruiting | PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial NCT06397560 | Baptist Health South Florida | N/A |
| Recruiting | BC008-1A Injection for Recurrent CNS WHO G4 Glioma NCT06773481 | Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd. | Phase 1 |
| Active Not Recruiting | Accelerating Motor Recovery in Glioma Patients Using Postoperative nrTMS NCT07285525 | Beijing Neurosurgical Institute | N/A |
| Not Yet Recruiting | PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique NCT06914427 | Xijing Hospital | N/A |
| Recruiting | Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients with Brain Lesions. NCT06797661 | Erasme University Hospital | N/A |
| Enrolling By Invitation | Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma NCT07126990 | Xiaorong Wu | Phase 1 / Phase 2 |
| Recruiting | Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline NCT06779487 | Tata Memorial Centre | — |
| Recruiting | Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Acro NCT06818331 | The Third Affiliated hospital of Zhejiang Chinese Medical University | Phase 2 |
| Suspended | Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM) NCT06855628 | Stanford University | Phase 2 |
| Recruiting | A Phase 2 Study of HX301 in Patients with High-grade Giloma NCT06703255 | Hangzhou Hanx Biopharmaceuticals, Ltd. | Phase 1 / Phase 2 |
| Recruiting | Irinotecan Liposomes Combined With Bevacizumab in the Treatment of Recurrent Glioma NCT06801730 | Zhifeng Tian,MD | Phase 2 |
| Recruiting | Craniospinal Irradiation in Histone AlteRed Midline Glioma NCT06720727 | Tata Memorial Centre | N/A |
| Recruiting | Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL NCT05460507 | Plus Therapeutics | Phase 1 |
| Recruiting | Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectabl NCT06650163 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Recruiting | Evaluation of the Variation Over Time of Visuospatial Deficit in Patients With Parietal Lobe Glioma NCT07286929 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | — |
| Recruiting | DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations NCT06988475 | Cancer Research UK | Phase 2 / Phase 3 |
| Completed | Evaluation of the Use of a Method "Radiomics" for DOPA PET in Gliomas NCT06472440 | Central Hospital, Nancy, France | — |
| Recruiting | A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without NCT06496971 | NaviFUS Corporation | Phase 3 |
| Active Not Recruiting | A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With NCT06413706 | Eli Lilly and Company | Phase 2 |
| Withdrawn | Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating Glio NCT04667715 | InSightec | N/A |
| Recruiting | Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblast NCT06329570 | NaviFUS Corporation | Phase 1 / Phase 2 |
| Recruiting | TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas NCT06640582 | Essen Biotech | Phase 1 / Phase 2 |
| Recruiting | Development of MRF for Characterization of Brain Tumors After Radiotherapy NCT06101069 | Case Comprehensive Cancer Center | N/A |
| Completed | Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy NCT06625047 | Mayo Clinic | Phase 4 |
| Recruiting | Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma NCT06344130 | National Cancer Institute (NCI) | Phase 1 |
| Not Yet Recruiting | Plasticizer Exposure and Its Consequences on Health NCT06512298 | Medical University of Vienna | — |
| Not Yet Recruiting | The Predictive Value of MRI for Adult-type Diffuse Gliomas NCT06572592 | First Affiliated Hospital, Sun Yat-Sen University | — |
| Recruiting | Investigating Mechanistic Predictors of Interpatient Variability and Temozolomide (TMZ) Induced Haematological NCT06546631 | University College Cork | — |
| Completed | Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent NCT06322342 | Reveal Pharmaceuticals Inc. | Phase 2 |
| Recruiting | 18F-Fluciclovine PET-MRI in High-grade Glioma NCT05553041 | Children's Hospital of Philadelphia | EARLY_Phase 1 |
| Recruiting | FIH Clinical Investigation of Graphene Electrodes for Brain Mapping NCT06368310 | University of Manchester | N/A |
| Not Yet Recruiting | Navigating the Clinical Research Process for Glioma NCT05958472 | Power Life Sciences Inc. | — |
| Not Yet Recruiting | Intraoperative Fluorescent Staining Combined With Microsurgery for Gliomas NCT06417372 | First Affiliated Hospital, Sun Yat-Sen University | — |
| Recruiting | Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas NCT06180434 | Erasmus Medical Center | — |
| Recruiting | FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery NCT06684795 | Rigshospitalet, Denmark | Phase 2 |
| Recruiting | Monitoring of Patients With Low-grade Gliomas Using Circulating miRNA NCT06610851 | University Hospital, Caen | — |
| Recruiting | Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes NCT06116903 | University Hospital, Limoges | N/A |
| Recruiting | A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors NCT06326411 | Nested Therapeutics, Inc | Phase 1 |
| Not Yet Recruiting | Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma NCT06368934 | Huashan Hospital | N/A |
| Recruiting | Effect of Electroacupuncture Combined With Paclitaxel Clinical Efficacy of Patients With Recurrence of High-gr NCT06330337 | The Third Affiliated hospital of Zhejiang Chinese Medical University | Phase 3 |
| Recruiting | Reducing Cognitive Impairment in Glioma with Repetitive Transcranial Magnetic Stimulation and Cognitive Strate NCT06043765 | Linda Douw | N/A |
| Suspended | IL13Rα2 CAR-T for Patients With r/r Glioma NCT06355908 | Yang Zhang | Phase 1 |
| Recruiting | Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality NCT06381726 | University of Milan | N/A |
| Withdrawn | Cereset for Caregivers NCT03935269 | Wake Forest University Health Sciences | N/A |
| Recruiting | Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring NCT05500391 | Centre Oscar Lambret | Phase 2 |
| Unknown | FCI in Post-operative Low Grade Gliomas NCT06294418 | NHS Grampian | N/A |
| Recruiting | Spatial and Temporal Characterization of Gliomas Using Radiomic Analysis NCT06036381 | Tata Memorial Centre | — |
| Unknown | CXCR4 PET/MRI Targeted Imaging for Grading Diagnosis, Molecular Typing, and Prognostic Evaluation of Brain Gli NCT06234319 | Xiao Chen | — |
| Unknown | Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas NCT06241391 | All India Institute of Medical Sciences, Bhubaneswar | N/A |
| Recruiting | PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications NCT06161519 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Active Not Recruiting | A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That NCT05916313 | Boehringer Ingelheim | Phase 1 |
| Recruiting | Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas NCT06454097 | Beijing Tiantan Hospital | N/A |
| Completed | Application of Cognitive Training Based on the Remind Strategy in Glioma Patients With Cognitive Impairment NCT06327048 | YuanYuan Ma | N/A |
| Recruiting | Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab NCT06011109 | Aveta Biomics, Inc. | Phase 1 / Phase 2 |
| Recruiting | Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Glioma NCT05937776 | OHSU Knight Cancer Institute | — |
| Recruiting | The Role of B7-H4 in Tumor Vaccine NCT06156150 | Huashan Hospital | — |
| Recruiting | Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas Gliomas NCT06620055 | Centro di Riferimento Oncologico - Aviano | — |
| Recruiting | NeuroPathways Intervention for Brain Tumor Patients NCT05976490 | Massachusetts General Hospital | N/A |
| Enrolling By Invitation | Cryoablation of Brain Neoplasm NCT06753617 | Erasmus Medical Center | N/A |
| Recruiting | Tumor Vaccines for Solid Tumors NCT06102837 | Huashan Hospital | — |
| Suspended | ExAblate Blood Brain Barrier Disruption (BBBD) for Planned Surgery in Suspected Infiltrating Glioma NCT03322813 | InSightec | N/A |
| Withdrawn | Contribution of [18F]DPA-714 PET for Grading and Exploration of the Inflammatory Microenvironment of Glioma. NCT05672082 | Center Eugene Marquis | N/A |
| Recruiting | Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi) NCT05968053 | Beijing Tiantan Hospital | — |
| Unknown | MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas NCT06043232 | Huashan Hospital | — |
| Recruiting | Registering Genomics and Imaging of Tumors (ReGIT) NCT05386043 | Indiana University | — |
| Recruiting | Evaluation of Diagnostic Performances of 18F-FDOPA PET KInetics NCT05512403 | Central Hospital, Nancy, France | Phase 3 |
| Recruiting | SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) NCT05303519 | Nuvation Bio Inc. | Phase 3 |
| Not Yet Recruiting | 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gli NCT05850377 | Sociedad de Lucha Contra el Cáncer del Ecuador | — |
| Unknown | MRI Contrast Clearance Analysis for Glioma Grading and Genotyping NCT06018870 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | — |
| Unknown | Evaluate the Accuracy of Raman IVD Analyzer in the Diagnosis of Gliomas During Surgery NCT05901844 | Beijing Tiantan Hospital | N/A |
| Recruiting | Use of Pulsed Low-dose Rate Re-irradiation for Recurrent Glioma (PULSAR) NCT06055517 | Centro di Riferimento Oncologico - Aviano | N/A |
| Recruiting | Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG NCT05773326 | Nader Sanai | EARLY_Phase 1 |
| Active Not Recruiting | Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis NCT05413304 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM) NCT05979064 | Northwell Health | N/A |
| Unknown | High-frequency nrTMS on the Contralateral Broca Mirror Area for Glioma Patients With Early Postoperative Aphas NCT05788445 | Beijing Neurosurgical Institute | N/A |
| Unknown | Accelerating Motor Recovering in Patients With SMA Syndrome After Glioma Surgery by Using nrTMS NCT05803057 | Beijing Neurosurgical Institute | N/A |
| Recruiting | Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-N NCT05259605 | European Organisation for Research and Treatment of Cancer - EORTC | — |
| Recruiting | MRS of Glioma Genomics NCT05700071 | Institut National de la Santé Et de la Recherche Médicale, France | N/A |
| Unknown | Evaluation of Role of Intraoperative Ultrasound in Gross Total Resection of Gliomas NCT05707728 | Assiut University | — |
| Recruiting | DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Posi NCT05768178 | Cancer Research UK | Phase 2 / Phase 3 |
| Recruiting | Neurocognition After Radiotherapy in CNS- and Skull-base Tumors NCT05727605 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Unknown | Analysis of Circulating DNA in Blood Samples of Glioma-affected Patients NCT05964153 | Corporacion Parc Tauli | N/A |
| Recruiting | Methimazole in Patients With Progressive Glioblastoma NCT05607407 | Case Comprehensive Cancer Center | Phase 2 |
| Recruiting | ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) NCT05580562 | Jazz Pharmaceuticals | Phase 3 |
| Recruiting | Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical Application NCT06883214 | Regina Elena Cancer Institute | — |
| Recruiting | Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China NCT05672043 | Beijing Tiantan Hospital | — |
| Recruiting | Use of CEST (Chemical Exchange Saturation Transfer) Imaging in PET/MRI NCT05464992 | Centre Paul Strauss | N/A |
| Recruiting | Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surge NCT06363162 | Beijing Tiantan Hospital | N/A |
| Unknown | MRI-based Computer Aided Diagnosis Software (V1) for Glioma NCT05739500 | Mingge LLC | — |
| Recruiting | A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With A NCT05538130 | Pfizer | Phase 1 |
| Recruiting | Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma. NCT05686798 | Henry Ford Health System | Phase 1 |
| Recruiting | All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma NCT05345002 | Stephen Bagley, MD, MSCE | Phase 2 |
| Completed | FearLess in Cognitively Intact Patients With Glioma NCT05604365 | Virginia Commonwealth University | N/A |
| Completed | Evaluation of the Incidence of NTRK Gene Fusion in Adult Brain Tumours NCT05025969 | GCS Ramsay Santé pour l'Enseignement et la Recherche | — |
| Recruiting | Platelets Activation in Brain Neoplasms NCT05049148 | Fondation Ophtalmologique Adolphe de Rothschild | N/A |
| Active Not Recruiting | Multimodal Machine Learning Characterization of Solid Tumors NCT04687969 | Ciprian Catana, MD, PhD | — |
| Active Not Recruiting | Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma Patients NCT05511324 | M.D. Anderson Cancer Center | N/A |
| Completed | A Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma NCT05577416 | Melbourne Health | EARLY_Phase 1 |
| Unknown | Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence NCT05611645 | Huashan Hospital | Phase 2 |
| Recruiting | 68Ga-NOTA-RM26 PET/CT in Glioma Patients NCT06412952 | Peking Union Medical College Hospital | EARLY_Phase 1 |
| Completed | Development and Validation of a Deep Learning-Based Survival Prediction Model for Pediatric Glioma Patients: A NCT06199388 | Tang-Du Hospital | — |
| Completed | Validity and Reliability Evaluation of the PRO-CTCAE for Adult-type Diffuse Gliomas Patients in Chinese Popula NCT05486923 | Huashan Hospital | — |
| Recruiting | Vascular Signature Mapping of Brain Tumor Genotypes NCT05274919 | Leiden University Medical Center | — |
| Completed | Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors NCT05383872 | InSightec | N/A |
| Recruiting | Glioma Developmental and HyperActive Ras Tumor (DHART) Board NCT05489783 | Memorial Sloan Kettering Cancer Center | — |
| Active Not Recruiting | Assessing Brain Metabolism Using MRS With Deuterated Glucose NCT06594315 | University of California, San Francisco | — |
| Recruiting | A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Al NCT05355701 | Pfizer | Phase 1 |
| Active Not Recruiting | AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients NCT05182905 | Nader Sanai | EARLY_Phase 1 |
| Completed | Brain Tumor Intraoperative Ultrasound Database NCT05062772 | Hospital del Rio Hortega | — |
| Unknown | Connectivity Alterations After Levetiracetam Application NCT04425798 | Beijing Neurosurgical Institute | — |
| Withdrawn | The KetoGlioma (Ketogenic Glioma) Study NCT05373381 | Tufts Medical Center | N/A |
| Unknown | Effects of Propofol on Auditory Event-related Potentials and Brain Functional Connectivity in Patients With Su NCT05352685 | Beijing Tiantan Hospital | N/A |
| Recruiting | Tumor Treating Fields for the Treatment of Brainstem Gliomas NCT05310448 | Emory University | N/A |
| Not Yet Recruiting | Mapping Molecular Markers of Brain Tumour Activity Using MRI NCT05140785 | King's College Hospital NHS Trust | N/A |
| Completed | Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery NCT05028400 | Insel Gruppe AG, University Hospital Bern | N/A |
| Unknown | ZOOMit-fMRI Identifies Language Functional Cortex NCT05188534 | Beijing Neurosurgical Institute | — |
| Recruiting | Pembrolizumab, Olaparib, and Temozolomide for People With Glioma NCT05188508 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | PERMA-Based Intervention on Negative Emotions, Adherence, and Complications in Postoperative Glioma Patients NCT06713395 | Yang Huang | N/A |
| Unknown | Glioma Brain Tumours - E12513 - SensiScreen Glioma NCT04539431 | Ente Ospedaliero Cantonale, Bellinzona | — |
| Recruiting | Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE) NCT05859659 | Yaou Liu | — |
| Unknown | Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific NCT05459441 | Shanghai Pudong Hospital | EARLY_Phase 1 |
| Unknown | Establishment and Evaluation of Multimodal Image Recognition System of Glioma Based on Deep Learning NCT04407039 | Tao Xin | — |
| Terminated | Assessment of Awake Surgery With Electrocorticographic Recordings in the Management of Gliomas and Correlation NCT05875935 | Ramsay Générale de Santé | N/A |
| Recruiting | LIQUID BIOPSY IN Low-grade Glioma Patients NCT05133154 | University Hospital, Montpellier | N/A |
| Withdrawn | Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma NCT05061251 | University of Texas Southwestern Medical Center | EARLY_Phase 1 |
| Unknown | Strategic Intervention on Preserving Motor Function During Awake Craniotomy NCT05143788 | Beijing Neurosurgical Institute | N/A |
| Unknown | Strategic Intervention on Preserving Language Function During Awake Craniotomy NCT05143775 | Beijing Neurosurgical Institute | N/A |
| Unknown | 68Ga-P16-093 PET/CT Imaging in Glioma Patients NCT05569434 | Peking Union Medical College Hospital | Phase 1 / Phase 2 |
| Recruiting | The circTeloDIAG: Liquid Biopsy for Glioma Tumor NCT04931732 | Hospices Civils de Lyon | — |
| Active Not Recruiting | Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma NCT05076513 | Nader Sanai | EARLY_Phase 1 |
| Recruiting | Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma NCT04543201 | University of Rochester | N/A |
| Completed | Ivosidenib (AG-120) With Nivolumab in IDH1 Mutant Tumors NCT04056910 | Jason J. Luke, MD | Phase 2 |
| Unknown | fMRI Study of Functional Reorganization in Glioma Patients NCT05019196 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Recruiting | Metabolic Characterization of Space Occupying Lesions of the Brain NCT04233788 | Insel Gruppe AG, University Hospital Bern | — |
| Unknown | [18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy NCT04870580 | University College, London | N/A |
| Active Not Recruiting | Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma NCT05045027 | Jonsson Comprehensive Cancer Center | EARLY_Phase 1 |
| Unknown | Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma NCT04902586 | Zhongnan Hospital | N/A |
| Unknown | Histomolecular Profiles of Gliomas in Children and Adolescent/Young Adults NCT04916015 | Centre Hospitalier Universitaire, Amiens | — |
| Unknown | Educating Brain Tumor Patients Using Patient-specific Actual-size Three-dimensional Printed Models NCT04970615 | Sümeyye Sezer | — |
| Recruiting | Study of GC101 TIL in Brain Glioma (Soochow2) NCT04943913 | Shanghai Juncell Therapeutics | EARLY_Phase 1 |
| Unknown | Use of Non-invasive Optical Analysis in Neurosurgery NCT04712214 | Imperial College London | N/A |
| Unknown | Research on Precise Immune Prevention and Treatment of Glioma Based on Multi-omics Sequencing Data NCT04792437 | Yu Yao, MD | — |
| Recruiting | LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138) NCT04699773 | University of Maryland, Baltimore | N/A |
| Unknown | Expression of ANXA2 in the Extracellular Space in the Microenvironment of Periumoral Edema Promotes Glioma Inv NCT04953468 | Peking University Third Hospital | — |
| Completed | 18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases NCT04752267 | University of Southern California | EARLY_Phase 1 |
| Suspended | Tumor Hypoxia and Proliferation in Patients With High-Grade Glioma NCT04309552 | Weill Medical College of Cornell University | Phase 1 |
| Terminated | Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma NCT03868943 | Wake Forest University Health Sciences | Phase 2 |
| Unknown | Transcranial Magnetic Stimulation in the Rehabilitation of Postoperative Motor Dysfunction. NCT04706338 | Beijing Neurosurgical Institute | N/A |
| Terminated | Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors NCT04541225 | Nuvation Bio Inc. | Phase 1 |
| Unknown | Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients. NCT04388033 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 1 / Phase 2 |
| Unknown | Anlotinib to Malignant Brainstem Glioma NCT04668508 | Zhejiang Cancer Hospital | Phase 2 |
| Recruiting | Tessa Jowell BRAIN MATRIX - Platform Study NCT04274283 | University of Birmingham | — |
| Unknown | The Study of Microglia/Macrophages Involved Dynamic Evolution of Glioma Microenvironment and the Function and NCT04781764 | Huashan Hospital | — |
| Suspended | Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diag NCT06387979 | Mayo Clinic | — |
| Active Not Recruiting | Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations NCT04521686 | Eli Lilly and Company | Phase 1 |
| Active Not Recruiting | Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Rad NCT04186832 | M.D. Anderson Cancer Center | N/A |
| Unknown | NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors NCT04550663 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 1 |
| Terminated | Enhanced Detection in Glioma Excision NCT04556929 | University of Oxford | N/A |
| Completed | An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors NCT04539574 | M.D. Anderson Cancer Center | N/A |
| Recruiting | Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose t NCT04975139 | Washington University School of Medicine | — |
| Recruiting | Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas NCT04772456 | University of Maryland, Baltimore | Phase 1 |
| Completed | 18F-FET PET/CT in the Management of Glioma NCT06563024 | Buddhist Tzu Chi General Hospital | N/A |
| Terminated | Infigratinib in Recurrent High-Grade Glioma Patients NCT04424966 | Nader Sanai | EARLY_Phase 1 |
| Completed | Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients NCT04446416 | NaviFUS Corporation | N/A |
| Unknown | Post-operative Imaging in High Grade Glioma: is Management Influenced? NCT04738110 | King's College Hospital NHS Trust | — |
| Completed | LY3214996 Plus Abemaciclib in Recurrent Glioblastoma Patients NCT04391595 | Nader Sanai | EARLY_Phase 1 |
| Completed | fMRI Reveal Functional Preservation in Glioma Peritumoral Edema NCT07343492 | West China Hospital | — |
| Completed | Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas NCT03532295 | Washington University School of Medicine | Phase 2 |
| Recruiting | MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma NCT04373720 | M.D. Anderson Cancer Center | N/A |
| Completed | Sulfasalazine and Stereotactic Radiosurgery for Recurrent Glioblastoma NCT04205357 | Haukeland University Hospital | Phase 1 |
| Unknown | Radiogenomic and Prognosis Analysis in Glioma NCT04122521 | Asan Medical Center | — |
| Recruiting | LITT Followed by Hypofractionated RT for Recurrent Gliomas NCT04181684 | University of Maryland, Baltimore | N/A |
| Suspended | Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recu NCT04222309 | Northwell Health | Phase 1 |
| Recruiting | Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies NCT04047264 | Mayo Clinic | N/A |
| Recruiting | Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors NCT03991832 | University Health Network, Toronto | Phase 2 |
| Recruiting | Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Mid NCT04185038 | Seattle Children's Hospital | Phase 1 |
| Withdrawn | Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma NCT04051047 | University of Michigan Rogel Cancer Center | EARLY_Phase 1 |
| Completed | Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Glioma NCT04114370 | James Mountz | EARLY_Phase 1 |
| Suspended | Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR NCT03952598 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas NCT03632317 | University of Michigan Rogel Cancer Center | Phase 2 |
| Completed | Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) NCT04461002 | GCS Ramsay Santé pour l'Enseignement et la Recherche | — |
| Unknown | Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies NCT03941626 | Shenzhen BinDeBio Ltd. | Phase 1 / Phase 2 |
| Recruiting | Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma NCT04065776 | St. Jude Children's Research Hospital | N/A |
| Withdrawn | StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain o NCT03990597 | M.D. Anderson Cancer Center | Phase 1 |
| Completed | Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas NCT04055688 | H. Lee Moffitt Cancer Center and Research Institute | — |
| Completed | 18F-Fluoro-Ethyl-Tyrosine (FET) Positron Emission Tomography (PET) and Grading Glioma NCT04001257 | University Hospital, Brest | — |
| Unknown | Organoids Derived From Induced-Pluripotent Stem Cells (iPS) From Patients With High Grade Astrocytoma NCT03971812 | Assistance Publique Hopitaux De Marseille | — |
| Completed | Social Determinants of Health in Glioblastoma Population NCT03900689 | Wake Forest University Health Sciences | — |
| Completed | Memory Perception Assessment in Central/Non-central Nervous System Cancers NCT03975959 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Unknown | TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT NCT03741244 | The Second Hospital of Hebei Medical University | Phase 2 |
| Active Not Recruiting | Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype NCT03718767 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption NCT03551249 | InSightec | N/A |
| Completed | EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS NCT03638167 | Seattle Children's Hospital | Phase 1 |
| Completed | Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients NCT03865355 | Novosibirsk State University | — |
| Terminated | Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases NCT03796273 | Wake Forest University Health Sciences | EARLY_Phase 1 |
| Recruiting | A Study Utilizing Escitalopram in Glioma Patients NCT03728673 | University of Nebraska | Phase 2 |
| Terminated | 68Ga-citrate PET/MR Imaging for Glioma NCT03335280 | Susan Chang | — |
| Terminated | Seizure Prophylaxis in Patients With Glioma or Brain Metastasis NCT03436433 | Duke University | Phase 2 |
| Recruiting | Non-invasive Glioma Characterization Through Molecular Imaging NCT03684109 | University of Miami | N/A |
| Completed | Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma NCT03027388 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Fo NCT03687957 | Washington University School of Medicine | Phase 1 / Phase 2 |
| Unknown | Revision of the EORTC QLQ-BN20 Questionnaire NCT04689321 | Leiden University Medical Center | — |
| Completed | Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI NCT04097535 | Imperial College London | — |
| Unknown | Biomarker-based Algorithm for Diagnosis of Glioma NCT04194593 | Hospices Civils de Lyon | — |
| Active Not Recruiting | Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With NCT03739372 | University of California, San Francisco | N/A |
| Completed | Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environme NCT03706625 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Multimodal Imaging of Hypoxia in Gliomas NCT03716986 | University Hospital, Caen | N/A |
| Unknown | Glioma Patients Registry Based on Radiological, Histopathological and Genetic Analysis NCT04220424 | The First Affiliated Hospital of Zhengzhou University | — |
| Unknown | Awake Intraoperative Language Mapping and Chinese Probabilistic Map Construction NCT03641391 | Huashan Hospital | N/A |
| Completed | Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients NCT03626896 | NaviFUS Corporation | N/A |
| Active Not Recruiting | HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumor NCT03500991 | Seattle Children's Hospital | Phase 1 |
| Active Not Recruiting | Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma NCT03514069 | Case Comprehensive Cancer Center | Phase 1 |
| Completed | Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery NCT05873946 | Hospital del Rio Hortega | — |
| Recruiting | Analysis of Circulating Tumor Markers in Blood NCT04025541 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Terminated | A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas NCT03593993 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | — |
| Unknown | Long Term Follow up of Patients Under 5 Years of Age With High Grade Glioma Diagnosed in France Between 1990 a NCT03690570 | University Hospital, Strasbourg, France | — |
| Withdrawn | Trial of IDH305 in IDH1 Mutant Grade II or III Glioma NCT02977689 | NYU Langone Health | Phase 2 |
| Completed | Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently NCT03496181 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Study of AG-120 and AG-881 in Subjects With Low Grade Glioma NCT03343197 | Institut de Recherches Internationales Servier | Phase 1 |
| Completed | Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms NCT03877861 | Allina Health System | — |
| Completed | SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies fo NCT03434262 | St. Jude Children's Research Hospital | Phase 1 |
| Unknown | Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma) NCT03463733 | M.E. van Linde | Phase 1 |
| Unknown | Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas NCT03423992 | Xuanwu Hospital, Beijing | Phase 1 |
| Unknown | Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies NCT03638206 | Shenzhen BinDeBio Ltd. | Phase 1 / Phase 2 |
| Recruiting | Seizure Treatment in Glioma NCT03048084 | Leiden University Medical Center | Phase 4 |
| Active Not Recruiting | Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant NCT03180502 | NRG Oncology | Phase 2 |
| Unknown | A Study of Apatinib in Recurrent or Recurrent High-grade Glioma NCT03390062 | West China Hospital | Phase 2 |
| Unknown | Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas NCT04216537 | The First Affiliated Hospital of Zhengzhou University | — |
| Completed | Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Express NCT03050736 | Kintara Therapeutics, Inc. | Phase 2 |
| Completed | MR Perfusion Methods in Patients With Suspected Recurrent High Grade Gliomas NCT02919865 | Ottawa Hospital Research Institute | N/A |
| Terminated | Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platele NCT03352427 | University of Michigan Rogel Cancer Center | Phase 2 |
| Withdrawn | Intratumorally-Administered Topotecan Using CED in High Grade Glioma Undergoing Stereotactic Biopsy NCT03193463 | Michael Vogelbaum, MD, PhD | EARLY_Phase 1 |
| Terminated | ONC201 in Adults With Recurrent H3 K27M-mutant Glioma NCT03295396 | Jazz Pharmaceuticals | Phase 2 |
| Terminated | VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM NCT03149575 | DelMar Pharmaceuticals, Inc. | Phase 3 |
| Completed | Cognitive Remediation Therapy for Brain Tumor Patients: Improving Working Memory NCT03323450 | Virginia Commonwealth University | N/A |
| Completed | The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma NCT03242824 | Mayo Clinic | Phase 2 |
| Completed | Quality of Life and Neurocognitive Functioning NCT03257618 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Active Not Recruiting | A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 NCT03152318 | Dana-Farber Cancer Institute | Phase 1 |
| Terminated | Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma NCT02743078 | RTOG Foundation, Inc. | Phase 2 |
| Terminated | Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors NCT03095248 | Children's Hospital Medical Center, Cincinnati | Phase 2 |
| Completed | Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma NCT03072134 | Northwestern University | Phase 1 |
| Completed | Resting-State Functional MRI in Glioma Patients Before and After Surgery NCT03964909 | M.D. Anderson Cancer Center | N/A |
| Unknown | Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggr NCT06348693 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Terminated | Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas NCT02507232 | Santosh Kesari | EARLY_Phase 1 |
| Terminated | A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) NCT02924038 | Nicholas Butowski | Phase 1 |
| Terminated | Improving Ultrasound Images in Brain Tumour Surgery With the Use of an Acoustic Coupling Fluid Mimicking Brain NCT03181581 | St. Olavs Hospital | Phase 2 |
| Completed | A Microdose Evaluation Study of ABY-029 in Recurrent Glioma NCT02901925 | Dartmouth-Hitchcock Medical Center | EARLY_Phase 1 |
| Terminated | [11C]Acetate PET in Patients With Glioma NCT02986815 | University of Texas Southwestern Medical Center | N/A |
| Completed | Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurre NCT02717962 | Kintara Therapeutics, Inc. | Phase 2 |
| Active Not Recruiting | Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas NCT03030066 | Daiichi Sankyo | Phase 1 |
| Completed | GlucoCEST MRI in Oncology NCT03212157 | University College, London | N/A |
| Withdrawn | Phase 2 Study of IDH305 in Low Grade Gliomas NCT02987010 | University of Texas Southwestern Medical Center | Phase 2 |
| Recruiting | Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial Intelligence NCT04215224 | The First Affiliated Hospital of Zhengzhou University | — |
| Recruiting | MR Based Prediction of Molecular Pathology in Glioma Using Artificial Intelligence NCT04217018 | The First Affiliated Hospital of Zhengzhou University | — |
| Recruiting | MR Based Survival Prediction of Glioma Patients Using Artificial Intelligence NCT04215211 | The First Affiliated Hospital of Zhengzhou University | — |
| Unknown | The Research on 89Zr-ABT806 PET Imaging in High Grade Glioma NCT03058198 | Huashan Hospital | N/A |